Protein Or Derivative Or Polysaccharide Or Derivative Patents (Class 424/418)
  • Patent number: 10285964
    Abstract: The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.
    Type: Grant
    Filed: July 22, 2016
    Date of Patent: May 14, 2019
    Assignee: ATRIUM MEDICAL CORPORATION
    Inventors: Thomas M. Swanick, Joseph Ferraro, Lisa Rogers, Paul Martakos
  • Patent number: 10232054
    Abstract: A polyion complex of mRNA and a polycationic polymer, and a composition and a pharmaceutical composition for mRNA delivery are provided. The polyion complex of mRNA and the polycationic polymer can deliver mRNA into cells in the body of a subject almost without inducing inflammation. The polyion complex can then cause mRNA to be uniformly expressed in cells in the body of the subject. The pharmaceutical composition containing the polyion complex is suitable for use in treating a disease whose condition rapidly progresses or an acute disease.
    Type: Grant
    Filed: February 12, 2014
    Date of Patent: March 19, 2019
    Assignee: AccuRna, Inc.
    Inventors: Kazunori Kataoka, Keiji Itaka, Takehiko Ishii, Hirokuni Uchida, Satoshi Uchida, Miyuki Baba
  • Patent number: 9510590
    Abstract: A method of delivering a biologically active chemical agent to an arthropod pest of a bee, comprising exposing a surface of the said bee to carnauba wax particles having a volume mean diameter of at least 10 ?m comprising at least one biologically active chemical agent, wherein the bee delivers the biologically active chemical agent to the arthropod pest, characterized in that the carnauba wax particles consist essentially of 89.5-99.4% by weight of carnauba wax; ?10% by weight of biologically active chemical agent; and 0.5% by weight of flow agent.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: December 6, 2016
    Assignee: Exosect Limited
    Inventors: Clare Gillian Storm, Nicola Jane Huggett
  • Patent number: 9427423
    Abstract: The present invention is directed toward fatty acid-based particles, and methods of making such particles. The particles can be associated with an additional, therapeutic agent. Also provided herein is a method of forming fatty acid particles, comprising associating a cross-linked, fatty acid-derived biomaterial with a cryogenic liquid; and fragmenting the bio material/cryogenic liquid composition, such that fatty acid particles are formed. The particles can be used for a variety of therapeutic applications.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: August 30, 2016
    Assignee: ATRIUM MEDICAL CORPORATION
    Inventors: Thomas M. Swanick, Joseph Ferraro, Lisa Rogers, Paul Martakos
  • Publication number: 20150110845
    Abstract: There is provided a polynucleotide-templated metal nanocluster for use in therapy. There is also provided use of a polynucleotide-templated metal nanocluster in the manufacture of a medicament for prophylactically or therapeutically treating a microbial infection as well as a method of prophylactically or therapeutically treating a microbial infection comprising administering to a subject a polynucleotide-templated metal nanocluster. There is also provided an antimicrobial agent comprising a polynucleotide-templated metal nanocluster.
    Type: Application
    Filed: October 10, 2014
    Publication date: April 23, 2015
    Inventors: Yen Nee Tan, Yuan Chong Jason Lim, Chao Wang, Lian Hui Zhang
  • Patent number: 8916162
    Abstract: Methods and compositions pertaining to botulinum neurotoxin (BoNT) light chain epitopes are provided. In particular, the methods and compositions relate to the use of real and mimetic BoNT light chain epitopes for generating an immune response in a subject, and for immunization against BoNT toxicity. Methods and compositions for detecting, isolating, and purifying BoNT epitopes and anti-BoNT antibodies are also provided.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: December 23, 2014
    Inventor: Alexey Gennadievich Zdanovsky
  • Publication number: 20140350452
    Abstract: The present invention is related to novel functional antibody coated nanoparticles, and the preparation method thereof. The functional antibody coated nanoparticles according to the present invention can be used as photothermal agents to effectively inhibit the growth of microbes including drug-resistant strains and biolfilm with laser irradiation.
    Type: Application
    Filed: May 23, 2013
    Publication date: November 27, 2014
    Inventors: Nancy J. Millenbaugh, Mauris DeSilva, Jonathan Baskin, William R. Elliot
  • Patent number: 8871234
    Abstract: Disclosed herein are UV-resistant gelatin/silica coated viral particles, methods for producing the same, and methods for controlling agricultural insect pests using the UV-resistant gelatin/silica coated viral particles.
    Type: Grant
    Filed: September 25, 2012
    Date of Patent: October 28, 2014
    Assignee: National Taiwan University
    Inventors: Chen Wei Shih, Hong-Ping Lin, Wen-Jer Wu, Shiang-Jiuun Chen, Rong-Nan Huang
  • Patent number: 8846003
    Abstract: This invention relates to collagen-binding synthetic peptidoglycans and engineered collagen matrices comprising a collagen matrix and a collagen-binding synthetic peptidoglycan where the collagen-binding synthetic peptidoglycan can be aberrant or can have amino acid homology with a portion of the amino acid sequence of a protein or a proteoglycan that regulates collagen fibrillogenesis. The invention also relates to kits, compounds, compositions, and engineered graft constructs comprising such collagen-binding synthetic peptidoglycans or engineered collagen matrices and methods for their preparation and use.
    Type: Grant
    Filed: March 27, 2009
    Date of Patent: September 30, 2014
    Assignee: Symic Biomedical, Inc.
    Inventors: Alyssa Panitch, John E. Paderi, Kinam Park, Katherine Stuart, Steve Higbee
  • Patent number: 8685425
    Abstract: Microcapsules possessing Lewis acid-Lewis base salt walls incorporate water-immiscible materials, such as N,N-di-ethyl-m-toluamide (DEET), as a core component. Such microcapsules, or similar microcapsules incorporating other core components, may be made by emulsifying a water-immiscible core component in an aqueous solution of one wall-forming reactant, such as the Lewis base, and then mixing that solution with the other wall-forming reactant, such as the Lewis acid. Various adjuvants may be included with the core component to contribute additional characteristics, such as enhancement of a controlled release characteristic or improved mechanical stability.
    Type: Grant
    Filed: October 17, 2011
    Date of Patent: April 1, 2014
    Inventor: Tycho J. Speaker
  • Publication number: 20140086969
    Abstract: Disclosed herein are UV-resistant gelatin/silica coated viral particles, methods for producing the same, and methods for controlling agricultural insect pests using the UV-resistant gelatin/silica coated viral particles.
    Type: Application
    Filed: September 25, 2012
    Publication date: March 27, 2014
    Applicant: National Taiwan University
    Inventors: CHEN WEI SHIH, Hong-Ping Lin, Wen-Jer Wu, Shiang-Jiunn Chen, Rong-Nan Huang
  • Patent number: 8568759
    Abstract: The present invention provides an environmentally compatible, pesticidal composition and method for the control of insect pests. The composition includes two components. The first component is a chelating agent, a metal complex of a chelating agent, and mixtures thereof, and the second component is preferably a carrier material.
    Type: Grant
    Filed: December 14, 2010
    Date of Patent: October 29, 2013
    Assignee: W. Neudorff GmbH KG
    Inventor: Diana L. Parker
  • Patent number: 8551951
    Abstract: The invention provides pharmaceutical compositions and method for inhibiting growth of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, or benign prostate hyperplasia (BPH). In one embodiment the pharmaceutical composition includes human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof. In another embodiment, the pharmaceutical composition includes a mixture of human rHuPSP94, antigenic portions thereof, and functionally equivalent polypeptides thereof and an anticancer drug which may be administered in an appropriate dosage form, dosage quantity and dosage regimen to a patient suffering from, for example of prostatic adenocarcinoma, stomach cancer, breast cancer, endometrial, ovarian or other cancers of epithelial secretion, benign prostate hyperplasia, or (BPH) gastrointestinal cancer.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: October 8, 2013
    Assignee: Aenorasis SA Pharmaceuticals and Medical Devices
    Inventors: Seema Garde, Chandra J. Panchal, Madhulika Baijal-Gupta, Jennifer Fraser, Salam Kadhim
  • Patent number: 8546487
    Abstract: The present invention provides an efficient delivery system for a nucleic acid, more specifically, a cationic poly(amino acid) that has a side chain having a plurality of different amine functional groups in a moiety including a cationic group and that has a hydrophobic group introduced into part of the side chain, and a polyion complex (PIC) of the poly(amino acid) and an oligo- or polynucleotide.
    Type: Grant
    Filed: February 15, 2010
    Date of Patent: October 1, 2013
    Assignee: The University of Tokyo
    Inventors: Kazunori Kataoka, Shourong Wu, Takehiko Ishii, HyunJin Kim, Kanjiro Miyata, Nobuhiro Nishiyama
  • Publication number: 20130243839
    Abstract: The invention relates to active particles, including core-shell particles, having low burst, controllable, sustained release which are useful for coating seeds. The active particles can also be used in sprayable and dry formulations for treating soil or plants. The particulate coating can also contain inert organic or inorganic material. The invention also relates to methods for preparing the active particles. The methods include: adding additional material to core particles to form a shell, removing active ingredient from a core surface to create an active-depleted shell, and crosslinking the outer layers of a core to form a shell.
    Type: Application
    Filed: August 8, 2012
    Publication date: September 19, 2013
    Applicant: Landec Corporation
    Inventors: David D. Taft, Damian Hajduk, Natarajan Balachander, Xinhua Zong, Qiang Zheng
  • Publication number: 20130236610
    Abstract: This application relates to compositions and methods for inhibiting the growth of potato pathogens preventing disease during post-harvest storage and processing conditions.
    Type: Application
    Filed: August 15, 2011
    Publication date: September 12, 2013
    Applicant: UNIVERSITY OF IDAHO
    Inventor: Phillip Wharton
  • Patent number: 8506971
    Abstract: The subject of the invention is a method for adjuvanting LPS of a Gram-negative bacterium, according to which LPS or LPS liposomes (LPS formulated in liposomes) is (are) mixed with the lipidated human-transferrin receptor subunit B (TbpB protein) of Neisseria meningitidis or a lipidated fragment thereof; or (ii) LPS and the lipidated TbpB of N. meningitidis or a lipidated fragment thereof are formulated together in liposomes; or (iii) LPS is conjugated with the lipidated TbpB of N. meningitidis or a lipidated fragment thereof; in order to obtain a preparation which does not contain OMVs and which is capable of inducing, after administration to a mammal, an anti-LPS immune response which is improved by comparison with the anti-LPS immune response observed after administration of the corresponding preparation in which the lipidated TbpB of N. meningitidis or a lipidated fragment thereof is omitted; as well as vaccine compositions thereof.
    Type: Grant
    Filed: May 14, 2010
    Date of Patent: August 13, 2013
    Assignee: Sanofi Pasteur S.A.
    Inventors: Jean Haensler, Bruno Guy
  • Patent number: 8501210
    Abstract: The present invention has an object to provide a gel composition which has an excellent skin whitening effect and shows high storage stability even when ascorbic acid, a salt of ascorbic acid, an ascorbic acid derivative, and a salt of an ascorbic acid derivative is blended, and to provide a pack cosmetic using the gel composition. The gel composition, which comprises the following components (A)-(D): (A) a tamarind seed polysaccharide; (B) a polyhydric alcohol; (C) at least one or more of ascorbic acid, a salt of ascorbic acid, an ascorbic acid derivative, and a salt of an ascorbic acid derivative; and (D) water.
    Type: Grant
    Filed: March 6, 2007
    Date of Patent: August 6, 2013
    Assignee: The Nisshin Oillio Group, Ltd
    Inventors: Masaaki Fujisawa, Keiko Tanaka, Keiichi Oyama
  • Patent number: 8501209
    Abstract: The invention provides a gel-type water absorbent with rich flexibility and elasticity, with less variation in strength of gel during preservation, with low viscosity of sol, with easy processability, having a physical property with extremely less water discharge, and having functions of water absorbency and water solubility. The gel-type water absorbent contains a tamarind seed polysaccharide including 90% or more dietary fiber, 1% or less protein and 1% or less ash; and a water-soluble organic substance including at least one or more of a polyhydric alcohol and water-soluble surfactant.
    Type: Grant
    Filed: May 16, 2005
    Date of Patent: August 6, 2013
    Assignee: The Nisshin Oillio Group, Ltd
    Inventors: Yukiko Oi, Keiichi Oyama, Yuji Uzuhashi, Masaaki Kojima
  • Patent number: 8481075
    Abstract: The present invention discloses preparation and application of a kind of biodegradable-material-made microsphere vascular embolus that contains liposome-encapsulated cytokines. The present invention is technologically characterized by encapsulation of liposome-wrapped immunocytokines such as IL-2, TNF and interferon by sodium polysaccharide or gelatin, which is extracted from natural alga and is good at biodegradability and biocompatibility. Owing to the encapsulation procedures, cytokine microspheres can take shape measuring 50-75 ?m, 75-150 ?m, 100-200 ?m, 200-300 ?m, 200-450 ?m, 100-300 ?m, 300-500 ?m, 500-700 ?m, and 700-900 ?m. The microsphere preparations are good targeting medication for embolism treatment and immunochemotherapy of animals loaded with human hepatocarcinoma and cervical cancer, as well as human suffering from late-stage or recurrent liver cancer, renal tumors, bladder cancer, colon carcinoma and rectal cancer.
    Type: Grant
    Filed: December 13, 2007
    Date of Patent: July 9, 2013
    Assignee: Beijing Shengyiyao Science & Technology Development Co. Ltd.
    Inventors: Li Xiaoping, Cui Heng, Wei Lihui, Feng Jie, Hong Hong, Li Xinjian, Qi Xianrong
  • Publication number: 20130167267
    Abstract: Novel processes and compositions are described which use viral capsid proteins resistant to hydrolases to prepare virus-like particles to enclose and subsequently isolate and purify target cargo molecules of interest including nucleic acids such as siRNA's and shRNA's, and small peptides.
    Type: Application
    Filed: December 21, 2012
    Publication date: June 27, 2013
    Applicant: APSE, LLC
    Inventor: Apse, LLC
  • Publication number: 20130142855
    Abstract: A method to control, inhibit, and kill pathogens and normal microbial strains that includes, but not limited to plant, animal and human pathogens, biofilm forming microbes, biofouling microbes, algae, fungi, bacteria, virus and protozoa using natural SL, MSL derivative and combinations thereof encompassed by the combination invention.
    Type: Application
    Filed: February 2, 2013
    Publication date: June 6, 2013
    Applicant: Polytechnic Institute of New York University
    Inventor: Polytechnic Institute of New York University
  • Patent number: 8399004
    Abstract: There is disclosed a method of controlling pests which comprises exposing a surface of the pest to a particulate composition containing particles of an initially unmagnetized material, which is capable of becoming magnetically polarized when subjected to an electric or magnetic field, the said particles being associated with at least one pesticide or behavior modifying chemical.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: March 19, 2013
    Assignee: Exosect Limited
    Inventors: Philip Howse, Karen Underwood
  • Publication number: 20120141571
    Abstract: An oil-in-water emulsion that is environmentally friendly and also exhibits antimicrobial activity is provided. More specifically, the oil phase of the emulsion includes a botanical oil derived from a plant (e.g., thymol, carvacrol, etc.). Because the botanical oil tends to leach out of the emulsion during storage and before it is used in the desired application, a water-dispersible polymer is also employed in the aqueous phase of the emulsion to enhance long term stability of the oil and, in turn, antimicrobial efficacy. Without intending to be limited by theory, it is believed that the water-dispersible polymer can effectively encapsulate the botanical oil within the emulsion and inhibit its premature release. Once the emulsion is formed, water can then be removed so that it becomes a substantially anhydrous concentrate. In this manner, the water-dispersible polymer will not generally disperse before use and prematurely release the botanical oil.
    Type: Application
    Filed: December 7, 2010
    Publication date: June 7, 2012
    Applicant: KIMBERLY-CLARK WORLDWIDE, INC.
    Inventors: Jaehong Lee, Vasily A. Topolkaraev, David W. Koenig, Neil T. Scholl, YoungSook Kim, James H. Wang
  • Patent number: 8124575
    Abstract: The present invention relates to a series of polyglycoside derivatives that are (a) polymeric (that is cross linked with hydroxypropyl linkages) and (b) contain additional functional groups including alkoxy, sulfate, sulfonate, quaternary and phosphate groups, and (c) sugars to increase water solubility and provide outstanding foaming agents and detergents that are naturally derived and readily biodegradable.
    Type: Grant
    Filed: December 16, 2009
    Date of Patent: February 28, 2012
    Assignee: SurfaTech Corporation
    Inventor: Anthony J. O'Lenick, Jr.
  • Patent number: 8084052
    Abstract: The invention herein provides for an improved pesticide that includes at least one attractant, at least one plant growth stimulator and an insecticide. The pesticide eradicates fire ants and promotes the destruction of empty nests by subsequent plant growth.
    Type: Grant
    Filed: January 12, 2009
    Date of Patent: December 27, 2011
    Inventors: James W. Mason, Marianne L. Mason
  • Patent number: 8067018
    Abstract: A microcapsule comprising a core material containing pyrethrin and a capsule shell wall which surrounds said core material, said shell wall material comprises gelatin and at least one polysaccharide selected from the group consisting of gum arabic and pectin is effective for controlling insects.
    Type: Grant
    Filed: February 16, 2007
    Date of Patent: November 29, 2011
    Assignee: Sumitomo Chemical Company, Limited
    Inventors: Yosuke Baba, Hidenori Eguchi
  • Patent number: 8039015
    Abstract: Microcapsules possessing Lewis acid-Lewis base salt walls incorporate water-immiscible materials, such as N,N-diethyl-m-toluamide (DEET), as a core component. Such microcapsules, or similar microcapsules incorporating other core components, may be made by emulsifying a water-immiscible core component in an aqueous solution of one wall-forming reactant, such as the Lewis base, and then mixing that solution with the other wall-forming reactant, such as the Lewis acid. Various adjuvants may be included with the core component to contribute additional characteristics, such as enhancement of a controlled release characteristic or improved mechanical stability.
    Type: Grant
    Filed: December 7, 2005
    Date of Patent: October 18, 2011
    Inventor: Tycho J. Speaker
  • Patent number: 8030471
    Abstract: The subject invention relates to nucleic acid sequences and amino acid sequences encoded thereby, derived from the Merozoite Surface Protein (MSP1) gene of the Plasmodium species P. malariae and P. ovale. Such genes and proteins have many beneficial diagnostic as well as therapeutic uses.
    Type: Grant
    Filed: June 20, 2008
    Date of Patent: October 4, 2011
    Assignee: Abbott Laboratories
    Inventors: Larry G. Birkenmeyer, Anthony S. Muerhoff, Suresh M. Desai, George J. Dawson, Bruce J. Dille
  • Patent number: 7931910
    Abstract: The present invention provides an environmentally compatible, pesticidal composition and method for the control of insect pests. The composition includes two components. The first component is a chelating agent, a metal complex of a chelating agent, and mixtures thereof, and the second component is preferably a carrier material.
    Type: Grant
    Filed: January 17, 2007
    Date of Patent: April 26, 2011
    Assignee: W. Neudorff GmbH KG
    Inventor: Diana L. Parker
  • Patent number: 7927811
    Abstract: The present invention relates to polypeptides having a brain-localizing activity, molecules comprising these polypeptides, and pharmaceutical agents that confer brain-localizing activity. The present inventors are the first to reveal amino acid motif sequences involved in brain-localizing activity. Polypeptides that comprise such motif sequences and have brain localizing activity were discovered as follows: DNAs encoding polypeptides comprising random amino acid sequences were synthesized, and incorporated into a phage library. The phage library produced was used to screen for polypeptides having brain-localized activity, which yielded such several polypeptides. These polypeptides comprised common sequences, which lead to the successful discovery of amino acid motif sequences involved in brain-localizing activity.
    Type: Grant
    Filed: August 6, 2004
    Date of Patent: April 19, 2011
    Assignee: Proteus Sciences Co., Ltd.
    Inventor: Makoto Sawada
  • Patent number: 7927543
    Abstract: The method is for treating a marine object. A composition is provided that has an organic substance. The composition is applied to the marine object. The composition has a first layer and a second layer. A first organic substance on the first layer attracts bacteria. The bacteria consume the first organic substance and during this process use oxygen. The bacteria thus reduce an oxygen level in a boundary layer adjacent to a surface of the marine object. The first layer of the composition erodes to expose the second layer. The bacteria consume a second organic substance of the second layer.
    Type: Grant
    Filed: October 5, 2007
    Date of Patent: April 19, 2011
    Assignee: Ekomarine AB
    Inventors: Mikael Haeffner, Claes Tarras Ericsson
  • Patent number: 7887817
    Abstract: A process for preventing a protozoal disease by the administration of an alkyl phosphocholine to a human being.
    Type: Grant
    Filed: January 8, 2003
    Date of Patent: February 15, 2011
    Assignee: AEterna Zentaris GmbH
    Inventor: Jürgen Engel
  • Publication number: 20100310621
    Abstract: A controlled release molecular iodine biocide for use in human cavities especially the vaginal, penile canal, nasal passages and rectum. Particles can be functionalized with epithelial cell binding molecules and lymphocyte-binding molecules attached to their surfaces. Half of all the particles can contain pH buffer salts that control pH to between around pH 3.5 to pH 4.5. A second half of the particles can contain Iodide and iodate salts. When pH particles and iodate/iodide particles are bound next to each other, molecular iodine is released in a controlled fashion. Molecular iodine is effective biocide. In an alternate embodiment, there can be two distinct populations of particles, one with epithelial cell binding molecules and one with lymphocyte-binding molecules. Again, half of all the particles can contain a pH buffer and half iodide and iodate salts.
    Type: Application
    Filed: June 4, 2010
    Publication date: December 9, 2010
    Inventor: James C. Richards
  • Patent number: 7776332
    Abstract: A composition for an infant formula which includes casein protein and whey protein; a method of producing the composition; use of the composition in the manufacture of a medicament or nutritional product for addressing malnutrition; and a method of addressing malnutrition which includes administering an effective amount of the composition are provided. The composition includes protein, free arginine; tryptophan and histidine, a lipid source and a carbohydrate source. In addition, the whey protein is sweet whey protein from which caseino-glyco-macropeptide has been removed.
    Type: Grant
    Filed: September 12, 2000
    Date of Patent: August 17, 2010
    Assignee: Nestec S.A.
    Inventors: Martinas Kuslys, Marie-Christine Secretin, Rolf Jost, Jean-Claude Maire, Olivier Ballevre, Ferdinand Haschke, Zdenek Kratky, Niklaus Meister
  • Patent number: 7758893
    Abstract: The present invention relates to an enteral composition containing phospholipids, triglycerides and cholesterol or precursors thereof, which can be used in the treatment of sepsis. With the composition of the invention the natural level of chylomicrons is maintained, in particular in gut associated lymphoid tissue (GALT), which ensures that most of LPS and/or LTA which are released in the body can be neutralized, substantially decreasing the risk of locally occurring high levels of LPS and/or LTA and thus sepsis.
    Type: Grant
    Filed: July 26, 2002
    Date of Patent: July 20, 2010
    Assignee: N.V. Nutricia
    Inventors: Robert Johan Joseph Hageman, Gelske Speelmans, Adrianus Johannes Maria Vriesema
  • Patent number: 7615539
    Abstract: The invention relates to a nucleic acid-lipophilic conjugates and methods for modulating an immune response using the conjugates. The lipophilic moiety associated with an immunostimulatory nucleic acid.
    Type: Grant
    Filed: September 27, 2004
    Date of Patent: November 10, 2009
    Assignees: Coley Pharmaceutical Group, Inc., Coley Pharmaceutical GmbH
    Inventors: Eugen Uhlmann, Jörg Vollmer, Arthur M. Krieg
  • Patent number: 7531187
    Abstract: A synergistic insecticidal composition is formed containing a Chloronicotynyle compound and a Pyrethroids compound. The Chloronicotynyle compound is provided in an amount preferably ranging from 0.1 to 5.0% by weight of the synergistic insecticidal composition. The Pyrethroids compound is provided in an amount preferably ranging from 1 to 60% by weight of the synergistic insecticidal composition. The synergistic insecticidal composition also preferably includes 35 to 98.90% by weight of conventional agriculturally acceptable carrier(s) and/or excipients.
    Type: Grant
    Filed: July 13, 2004
    Date of Patent: May 12, 2009
    Assignee: United Phosphorus, Ltd.
    Inventors: Prakash Mahadev Jadhav, Jaidev Rajnikant Shroff
  • Patent number: 7498028
    Abstract: The invention relates to surfactant-free reagent spheres useful for biological tests particularly those involving antigen/antibody reactions.
    Type: Grant
    Filed: June 14, 2007
    Date of Patent: March 3, 2009
    Inventors: Susan Goertz, Paul Hemmes
  • Publication number: 20080292675
    Abstract: The invention relates to a medicotechnical product having an antimicrobial finish consisting of a complex material of metal nanoparticles and macromolecules, the macromolecules being at least partially formed from amphiphilically modified polyamino acids which contain amino acid units, which aside from the functional groups bonded in the peptide bond contain at least one further functional group and at least some of these groups are modified with substances bearing hydrophobic radicals via covalent bonds. The hydrophobic radicals are bonded by addition of substances bearing epoxy groups to the at least one further functional group and/or via at least one amino group of an amino acid unit bearing at least one amino group as a further functional group with maintenance of an amino function on the polyamino acids. The invention furthermore relates to the production of the complex material and of the medicotechnical product.
    Type: Application
    Filed: March 6, 2008
    Publication date: November 27, 2008
    Inventors: Erich Edermatt, Ingo Berndt, Joerg Tiller, Chau Hon Ho
  • Patent number: 7449196
    Abstract: An anti-cancer composition having biocompatible materials, which can selectively exploit chemical variations between normal cells and cancer cells to inhibit or prevent the proliferation of cancerous cells and methods of use.
    Type: Grant
    Filed: July 9, 2004
    Date of Patent: November 11, 2008
    Inventor: Robert Sabin
  • Patent number: 7445791
    Abstract: A synergistic insecticidal composition is prepared by combining a Chloronicotynyle compound and an Organophosphorus (OP) compound. The preferred synergistically effective amount of the Chloronicotynyle compounds is an amount preferably ranging from 0.1 to 5% by weight of the composition. The preferred synergistically effective amount of the Organophosphorus (OP) compounds is an amount preferably ranging from 30 to 75% by weight of the composition. The composition also preferably includes 69.9 to 20% by weight of conventional agriculturally acceptable carrier(s) and/or excipient.
    Type: Grant
    Filed: July 12, 2004
    Date of Patent: November 4, 2008
    Assignee: United Phosphorus, Ltd.
    Inventors: Prakash Mahadev Jadhav, Jaidev Rajnikant Shroff
  • Patent number: 7425528
    Abstract: The present invention relates to granules comprising a core matrix and one or more coatings, wherein the core matrix comprises: An active compound, a synthetic polymer, where the amount of polymer added is 0.1 to 10% by weight of the matrix and one or more antioxidants and/or reducing agents, where the amount of antioxidant and/or reducing agent is 0.2 to 5% by weight of the matrix.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: September 16, 2008
    Assignee: Novozymes A/S
    Inventors: Ole Simonsen, Erik Kjaer Markussen, Hanne Rojel, Svend Kaasgaard, Thomas Honger Callisen, Christian Isak Jorgensen
  • Publication number: 20080213329
    Abstract: A method of delivering a biologically active agent to a target site comprising exposing a surface of a non-target carrier organism to a carrier comprising at least one biologically active agent, wherein the non-target carrier organism delivers the biologically active agent to the target site.
    Type: Application
    Filed: May 10, 2006
    Publication date: September 4, 2008
    Applicant: EXOSECT LIMITED
    Inventor: Ian Hamilton Baxter
  • Patent number: 7335627
    Abstract: The products of the invention are polymers of carboxylated alkylpolyglycosides. The products are very mild surfactants that are useful in personal care applications.
    Type: Grant
    Filed: May 25, 2006
    Date of Patent: February 26, 2008
    Assignee: Surfa Tech Corporation
    Inventors: Kevin Anthony O'Lenick, Anthony J. O'Lenick, Jr.
  • Patent number: 7256000
    Abstract: The invention relates to surfactant-free reagent spheres useful for biological tests particularly those involving antigen/antibody reactions.
    Type: Grant
    Filed: July 5, 2002
    Date of Patent: August 14, 2007
    Assignee: Spectral Diagnostics
    Inventors: Susan Goertz, Paul Hemmes
  • Patent number: 7163687
    Abstract: The present invention provides a shelf-life extending pesticide formulation, and methods of making and methods of use. The present invention prolongs the shelf-life many fold. In addition, methods of controlling insects on cattle are also provided.
    Type: Grant
    Filed: March 4, 2004
    Date of Patent: January 16, 2007
    Assignee: Wellmark International
    Inventors: Dennis Lee Murphy, Jeanne Ann Witte, Kim W. Yang
  • Patent number: 7125696
    Abstract: A invention concerns a novel method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent, and polypeptides obtainable by said method. The invention also concerns the use of said polypeptides, in particular for preparing medicines or vaccines, for fighting against bacterial and viral infections or cancers.
    Type: Grant
    Filed: January 4, 2001
    Date of Patent: October 24, 2006
    Assignee: Pierre Fabre Medicament
    Inventors: Thierry Baussant, Pascale Jeannin, Yves Delneste, François Lawny, Jean-Yves Bonnefoy
  • Patent number: 7122176
    Abstract: The present invention utilizes the pre-sporulation (preconidial) mycelial stage of entomopathogenic fungi as insect attractants and/or pathogens. The fungus can be cultivated on grain, wood, agricultural wastes or other cellulosic material, attracting the insect and optionally introducing insect-specific pathogenic fungi. More than one fungus and substrate can be used in combination. The matrix of preconidial fungi can optionally be dried, freeze-dried, cooled and/or pelletized and packaged and reactivated for use as an effective insect attractant and/or biopesticide. Attractant extracts of the preconidial entomopathogenic mycelium are disclosed.
    Type: Grant
    Filed: October 1, 2001
    Date of Patent: October 17, 2006
    Assignee: Mycosys, LLC
    Inventor: Paul Edward Stamets
  • Patent number: 7087246
    Abstract: A controlled release preparation of insulin and its method are provided. The controlled release preparation of insulin contains microparticles obtained by microencapsulation of uniform microcystals of insulin using biodegradable polymeric materials. Since the denaturation of insulin that may occur during microencapsulation is reduced, the stability of the preparation can be increased. Also, the ratio of insulin to a polymer carrier is increased, which is suitable for pulmonary delivery. Further, the controlled release preparation of insulin can continuously exhibit pharmaceutical efficacy in vivo in a stable manner for an extended period of time.
    Type: Grant
    Filed: June 25, 2001
    Date of Patent: August 8, 2006
    Assignee: Mi Tech Company Limited
    Inventors: Chan-Hwa Kim, Jai-Hyun Kwon, Sung-Hee Choi